Home » Pipeline
Pipeline
June 28, 2021
| Company | Drug/Device | Medical Condition | Status |
|---|---|---|---|
| Nanoscope Therapeutics | MCO-010 | advanced retinitis pigmentosa | IND approved by the FDA for a phase 2b trial |
| Hope Biosciences Stem Cell Research Foundation | intravenous infusions of allogeneic adipose-derived mesenchymal stem cells | Parkinson’s disease | IND approved by the FDA for a phase 2 trial |
| Prestige Biopharma | PBP1510 | pancreatic cancer | clinical trial authorized by the French National Agency for the Safety of Medicines and Health Products for a phase 1/2 trial |
| Roche | cobas SARS-CoV-2 nucleic acid test for use on the cobas Liat System | RT-PCR test to identify SARS-CoV-2 infection | Emergency Use Authorization granted by the FDA |
| Boehringer Ingelheim | Pradaxa (dabigatran etexilate) oral pellets and capsules | venous thromboembolism in children three months to less than 12 years old | approved by the FDA for expanded indication and new formulations |
| Becton, Dickinson and Company | PeritX peritoneal catheter system | drainage of symptomatic, recurrent nonmalignant ascites | approved by the FDA |
| CoreLink | F3D corpectomy vertebral body replacement system | replacement of damaged vertebral bodies in the cervical and thoracolumbar spine | approved by the FDA |
| Fist Assist Devices | FA-1 device | focal arm massage and increased arm vein circulation | approved by the FDA |
| Onkos Surgical | Eleos limb salvage system | to support bone in-growth in musculoskeletal oncology and complex orthopedic limb salvage cases | approved by the FDA |
| Integrity Implants | FlareHawk expandable lumbar interbody fusion device | spinal intervertebral body fusion | approved in the European Union |
| AstraZeneca HutchMed |
savolitinib | treatment of patients with nonsmall-cell lung cancer with MET exon 14 skipping alterations who have progressed following prior systemic therapy or are unable to receive chemotherapy | approved in China |
| Beigene | tislelizumab | first-line treatment of advanced nonsquamous, nonsmall-cell lung cancer and patients with hepatocellular carcinoma who have been previously treated with at least one systemic therapy | approved in China |
| Fosun Kite Biotechnology | axicabtagene ciloleucel | treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy | approved in China |
| Amgen | Aimovig (erenumab) | suppression of onset of migraine attacks in adults | approved in Japan |
| CardioFocus | HeartLight X3 system | catheter ablation for controlled and consistent pulmonary vein isolation | approved in Japan |
| Poxel Sumitomo Dainippon Pharma |
Twymeeg (imeglimin hydrochloride) | type 2 diabetes | approved in Japan |
Upcoming Events
-
28Sep
-
12Oct
-
18Oct
